NEW YORK, NY / ACCESSWIRE / September 5, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Abiomed, Inc. (“Abiomed” or the Company”) (NASDAQ ABMD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Abiomed securities between January 31, 2019 through July 31, 2019, both dates inclusive. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

source https://finance.yahoo.com/news/shareholder-alert-abiomed-inc-abmd-143000803.html?.tsrc=rss